These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 25400479)

  • 1. Amenorrhea as a rare drug-related adverse event associated with everolimus for pancreatic neuroendocrine tumors.
    Kawaguchi Y; Maruno A; Kawashima Y; Ito H; Ogawa M; Mine T
    World J Gastroenterol; 2014 Nov; 20(42):15920-4. PubMed ID: 25400479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of endoscopic ultrasonography-guided fine needle aspiration for pancreatic neuroendocrine tumor grading.
    Sugimoto M; Takagi T; Hikichi T; Suzuki R; Watanabe K; Nakamura J; Kikuchi H; Konno N; Waragai Y; Asama H; Takasumi M; Watanabe H; Obara K; Ohira H
    World J Gastroenterol; 2015 Jul; 21(26):8118-24. PubMed ID: 26185384
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [A case of massive pancreatic neuroendocrine carcinoma successfully treated with surgical resection and postoperative everolimus administration].
    Mukai Y; Takeda Y; Nakahira S; Katsura Y; Kusama H; Hashimoto N; Matsushita K; Kawashima H; Hamanaka M; Kagawa Y; Takeno A; Okishiro M; Sakisaka H; Suzuki R; Egawa C; Taniguchi H; Kato T; Tamura S
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1887-9. PubMed ID: 24393955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful everolimus treatment in a patient with advanced pancreatic neuroendocrine tumor who developed everolimus-induced interstitial lung disease on two occasions: a case report.
    Nakayama Y; Ikeda M; Kojima M; Goto K; Hara M; Okuyama H; Takahashi H; Ohno I; Shimizu S; Mitsunaga S; Okusaka T
    Chemotherapy; 2013; 59(1):74-8. PubMed ID: 23867634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Everolimus dramatically improves glycemic control in unresectable metastatic insulinoma: a case report.
    Asayama M; Yamada-Murano T; Hara H; Ooki A; Kurosumi M; Yamaguchi K
    Jpn J Clin Oncol; 2014 Feb; 44(2):186-90. PubMed ID: 24367043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of everolimus in pancreatic neuroendocrine tumors.
    Goldstein R; Meyer T
    Expert Rev Anticancer Ther; 2011 Nov; 11(11):1653-65. PubMed ID: 21932937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pancreatic neuroendocrine tumors: entering a new era.
    Oberstein PE; Remotti H; Saif MW; Libutti SK
    JOP; 2012 Mar; 13(2):169-73. PubMed ID: 22406593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Everolimus: a new treatment option for advanced pancreatic neuroendocrine tumors.
    Thompson LA; Kim M; Wenger SD; O'Bryant CL
    Ann Pharmacother; 2012 Sep; 46(9):1212-9. PubMed ID: 22947595
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Everolimus and sunitinib: from mouse models to treatment of pancreatic neuroendocrine tumors.
    Liakakos T; Roukos DH
    Future Oncol; 2011 Sep; 7(9):1025-9. PubMed ID: 21919689
    [No Abstract]   [Full Text] [Related]  

  • 10. Significant efficacy of new transcatheter arterial chemoembolization technique for hepatic metastases of pancreatic neuroendocrine tumors.
    Akahori T; Sho M; Tanaka T; Nishiofuku H; Kinoshita S; Nagai M; Kichikawa K; Nakajima Y
    Anticancer Res; 2013 Aug; 33(8):3355-8. PubMed ID: 23898103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The FGFR4-G388R single-nucleotide polymorphism alters pancreatic neuroendocrine tumor progression and response to mTOR inhibition therapy.
    Serra S; Zheng L; Hassan M; Phan AT; Woodhouse LJ; Yao JC; Ezzat S; Asa SL
    Cancer Res; 2012 Nov; 72(22):5683-91. PubMed ID: 22986737
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Management of metabolic disorders induced by everolimus in patients with differentiated neuroendocrine tumors: expert proposals].
    Lombard-Bohas C; Cariou B; Vergès B; Coriat R; N'guyen T; François E; Hammel P; Niccoli P; Hentic O
    Bull Cancer; 2014 Feb; 101(2):175-83. PubMed ID: 24557872
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Two Cases of Pancreatic Neuroendocrine Tumor with Liver Metastases Successfully Treated with Multidisciplinary Therapy including Multiple Surgical Resections].
    Akiyama T; Yoshitomi H; Shida T; Shimizu H; Ohtsuka M; Kato A; Furukawa K; Takayashiki T; Kuboki S; Takano S; Okamura D; Suzuki D; Sakai N; Kagawa S; Miyazaki M
    Gan To Kagaku Ryoho; 2015 Nov; 42(12):2397-9. PubMed ID: 26805376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Synchronous metastases to the liver and pancreas from a primary neuroendocrine carcinoma of the breast diagnosed by fine-needle aspiration.
    McIntire M; Siziopikou K; Patil J; Gattuso P
    Diagn Cytopathol; 2008 Jan; 36(1):54-7. PubMed ID: 18064696
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Everolimus causing severe hypertriglyceridemia and acute pancreatitis.
    Subramaniam S; Zell JA; Kunz PL
    J Natl Compr Canc Netw; 2013 Jan; 11(1):5-9. PubMed ID: 23307976
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Everolimus 10 mg and pancreatic neuroendocrine tumours: many adverse effects and uncertain benefit.
    Prescrire Int; 2012 Oct; 21(131):234. PubMed ID: 23185844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Everolimus Related Fulminant Hepatitis in Pancreatic Neuroendocrine Tumor With Liver Metastases: A Case Report and Literature Review.
    Chang SC; Tsai CY; Liu KH; Wang SY; Hsu JT; Yeh TS; Yeh CN
    Front Endocrinol (Lausanne); 2021; 12():639967. PubMed ID: 33868173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Long-term everolimus treatment of patients with pancreatic neuroendocrine tumors.
    Wolin EM
    Chemotherapy; 2014; 60(3):143-50. PubMed ID: 25766415
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of pancreatic endocrine carcinoma with a different clinical diagnosis before chemotherapy and pathological autopsy.
    Jubashi A; Yamaguchi D; Ogata R; Nagatsuma G; Hara Y; Tanaka Y; Yoshioka W; Hino N; Morisaki T; Ario K; Matsuoka Y; Taba M; Naito S; Tsunada S
    Clin J Gastroenterol; 2022 Feb; 15(1):237-243. PubMed ID: 34689312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endoscopic ultrasound-guided fine-needle aspiration cytology of pancreatic neuroendocrine tumors: a study of 48 cases.
    Chatzipantelis P; Salla C; Konstantinou P; Karoumpalis I; Sakellariou S; Doumani I
    Cancer; 2008 Aug; 114(4):255-62. PubMed ID: 18618505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.